Table 1 Demographics between patients with sarcopenia and without sarcopenia

Patients (number)

112 (67.1%)

55 (32.9%)

Age (years)^a

63.1 ± 11.6

60.5 ± 11.5

0.152

Gender, n

< 0.001

 Male

90(53.9%)

28(16.8%)

 Female

22(13.2%)

27(16.2%)

Weight (kg)^a

57.2 ± 9.8

63.5 ± 9.3

< 0.001

Height (m)^a

1.64 ± 0.08

1.62 ± 0.08

0.028

Body mass index, (kg/m²)^a

21.1 ± 3.2

24.3 ± 3.1

< 0.001

 Creatinine, mg/dL

3.6 ± 1.10

3.3 ± 0.71

0.157

 HbA_1c, %

 Fasting glucose level, mg/dL

7.6 ± 0.7

158.2 ± 23.3

7.6 ± 0.73

161.4 ± 25.8

0.851

0.421

 Hypertension (yes/no)

36(32.1%) / 76(67.9%)

18(32.7%) / 37(67.3%)

0.981

 Cardiac disease (yes/no)

27(24.1%) / 85(75.9%)

0.498

 Pulmonary disease (yes/no)

10(8.9%) / 102(91.1%)

10(18.2%) / 45(81.8%)

0.514

 Cerebrovascular disease (yes/no)

12(10.7%) / 100(89.3%)

7(12.7%) / 48(87.3%)

0.574

 Renal disease (yes/no)

52(46.4%) / 60(53.6%)

4(7.3%) / 51(92.7%) 24(43.6%) / 31(56.4%)

0.582

Minor LEA (number)

78(69.6%)

46(83.6%)

 Toe

29

11

 Ray

27

25

 Transmetatarsal

22

10

Major LEA (number)

34(30.4%)

9(16.4%)

 Below knee

29

8

 Above knee

5

1